Skip to content

Intravascular ultrasound in patients with chronic limb threatening ischemia of the lower leg.

Impact of intravascular ultrasound (IVUS) imaging on procedural decision-making in below the knee endovascular treatment for critical limb ischemia (CLI): a pilot study. - IVUS in CLTI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57943
Enrollment
25
Registered
2025-03-20
Start date
2026-02-24
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical limb ischemia, diabetes, diabetic foot ulcers

Interventions

In this study, we will use the intravascular ultrasound (IVUS) catheter by Philips. The IVUS catheter is a special catheter with s a transducer on one end, to generate sound waves and produce pictures

Sponsors

Haaglanden Medisch Centrum (HMC)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Written informed consent Age: > 18 years old Critical Limb Ischemia, Rutherford category, 5 (minor tissue loss) or 6 (major tissue loss) in the lower legsEndovascular treatable stenosis or occlusions of the crural vessels Referred for below the knee endovascular treatment

Exclusion criteria

Exclusion criteria: Per procedural inability to cross the below the knee arteries stenosis / occlusions.Acute limb ischemiaSub-acute limb ischemia which requires thrombolysis as first treatment modalityPrevious major amputation of the affected limb (at or above the level of the ankle)Previous endovascular or surgical intervention below the knee of the index leg (<6 months ago)Patient unable or unwilling to tolerate standard contrast mediaNot correctable coagulopathy conform HMC protocol

Design outcomes

Primary

MeasureTime frame
Percentage of procedural decision changes (e.g. different size balloon, stent, prolonged PTA) based on the IVUS analysis after the intervention. We hypothese that in 30% of all cases IVUS will alter procedural decisions.  

Secondary

MeasureTime frame
Differences in vessel sizing DSA images compared to IVUS.Differences in technical success (<30% stenosis) in DSA and IVUS, compared to DSA alone (compared to matched cases).Differences in clinical parameters (wound healing and major amputations above ankle) in the patient group with technical success at DSA and IVUS, compared to technical success at DSA only.Additional time for IVUS use during endovascular treatment.

Countries

Netherlands

Contacts

Public ContactJ.M. Baars

Haaglanden Medisch Centrum (HMC)

jade.baars@haaglandenmc.nl088 979 6825

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026